Drug holiday vs. continuous therapy: which works better for sarcoma?
NCT ID NCT01303094
First seen Mar 19, 2026 · Last updated May 19, 2026 · Updated 16 times
Summary
This study looked at 53 adults with advanced soft tissue or uterine sarcoma who had stable disease or responded after six cycles of trabectedin. Half continued the drug, while the other half took a break (drug holiday). The goal was to see which approach better delayed cancer growth and reduced side effects. Results help guide treatment decisions for managing this rare cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOFT TISSUE SARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU Timone Adultes
Marseille, 13385, France
-
Centre Antoine Lacassagne
Nice, 06189, France
-
Centre François Baclesse
Caen, 14076, France
-
Centre Georges François Leclerc
Dijon, 21079, France
-
Centre Henri Becquerel
Rouen, 76038, France
-
Centre Jean Perrin
Clermont-Ferrand, 63011, France
-
Centre Léon Bérard
Lyon, 69008, France
-
Centre Oscar Lambret
Lille, 59020, France
-
Centre René Huguenin
Saint-Cloud, 92210, France
-
Institut Bergonié
Bordeaux, 33076, France
-
Institut Claudius Regaud
Toulouse, 31052, France
-
Institut Curie
Paris, 75005, France
-
Institut Gustave Roussy
Villejuif, 94805, France
-
Léon Bérard Center
Lyon, 69 008, France
-
Paoli Calmette Institute
Marseille, 13 273, France
-
Saint-Jacques Hospital
Besançon, 25 000, France
Conditions
Explore the condition pages connected to this study.